Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India

Journal of Infection in Developing Countries

Volumn 5, Issue 12, 2011, Pages 874-881

  Sharma, Hitt J ^a   Padbidri, Vasant S ^b   Kapre, Subhash V ^a   Jadhav, Suresh S ^a   Dhere, Rajeev M ^a   Parekh, Sameer S ^a   Dudhane, Ashok D ^b   Shewale, Sunil D ^a   Namjoshi, Gajanan S ^c  

^a Serum Institute of India Ltd   (India)

^b KEM HOSPITAL   (India)

^c Earlier with Serum Institute of India Ltd   (India)

Author keywords

Immunogenicity; Rubella; Safety; Serological survey

Indexed keywords

R VAC; RUBELLA ANTIBODY; RUBELLA VACCINE; UNCLASSIFIED DRUG;

ADOLESCENCE; ADOLESCENT; ANAPHYLAXIS; ANTIBODY BLOOD LEVEL; ARTHRALGIA; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DRUG MONITORING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGENICITY; INDIA; INJECTION SITE ERYTHEMA; INJECTION SITE NODULE; INJECTION SITE PAIN; INJECTION SITE RASH; INJECTION SITE SWELLING; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MYALGIA; PHASE 4 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RUBELLA; RURAL AREA; SCHOOL CHILD; SEROLOGY; SEROPREVALENCE; URBAN AREA; VIRUS IMMUNITY;

EID: 83755186394     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.1847     Document Type: Article

References (15)

1. World Health Organization (2000) Position paper Rubella vaccine. Weekly Epidemiological Record, No. 20, 19 May 2000; 75: 161-172.
2. Vijaylakshmi P, Anuradha R, Prakash K, Narendran K, Ravindran M, Prajna L, Brown D, Robertson SE (2004) Rubella sero-surveys at three Arvind Eye Hospitals in Tamil Nadu, India. Bulletin of the World Health Organization 82: 259-64.
3. Rai A, Kumari S, Khare S, Gandhoke I, Bhatia R, Datta KK (19950 Maternal viral infections and implications in Congenital defects of new borns. J Basic and Applied biomedicine 3: 1-9.
4. Khare S, Banerjee K, Padbidri V, Rai A, Kumar S (1987) Lower immunity status of rubella virus infection in pregnant women. J Com Dis 19: 391-395.
5. Yadav S, Gupta S, Kumari S (1995) Sero-prevalence of rubella in women of reproductive age group. Indian J Pathol Microbiol 38: 139-142.
6. Gupta E, Dar L, Broor S (2006) Sero-prevalence of rubella in pregnant women in Delhi, India. Indian J Med Res 123: 833-835.
7. Robertson SE, Cutts FT, Samuelr, Diaz-Ortega JL (1997) Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: vaccination against rubella. Bulletin of the World Health Organization 75: 69-80.
8. Measles, Mumps, and Rubella: Vaccine Use and Strategies for Elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. May 22, 1998/ Vol. 47/ No. RR-8.
9. Bhaskaram P, Ramalakshmi BA, Ramaraju LA, Raman L (1991) Need for protection against Rubella in India. Indian J Pediatr 58: 811-814.
10. Chakrabarty MS, Das BC, Gupta B, Sarkar JK (1975) Rubella as an aetiological factor for congenital malformation in Calcutta: A serological study. Indian J Med Res63: 1438-1445.
11. Seth P, Balaya S, Mohapatra LN (1971) Sero-epidemiological study of Rubella infection in female subjects of Delhi and its surrounding villages. Indian J Med Res 59: 190-194.
12. N Singla, N Jindal, A Aggarwal (2004) The sero-epidemiology of rubella in Amritsar (Punjab), Indian Journal of Medical Microbiology 22: 61-63.
13. Hitt Sharma, Sunil Chowdhari, Tilak Raj Raina, Subodh Bhardwaj, Gajanan Namjoshi, Sameer Parekh (2010) A sero-survey, immunogenicity and safety of Rubella vaccine in peri-pubertal, seronegative Indian schoolgirls girls aged 11- 18 years. Indian Journal of Community Medicine 35:134-137.
14. The goal of eliminating measles and rubella and prevention of CRS (2010) WHO Regional Committee meeting, Europe. September 2010.
15. Hinman AR, Irons B, Lewis M, Kandola K (2001) Economic analyses of rubella and rubella vaccines: a global review. Bull World Health Organ. 80: 264-270.